Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
ASCO 2014 – Immuno-Oncology
First Trial Assessing Nivolumab in Platinum-Resistant Ovarian Cancer
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Phase 2 Trial of Nivolumab in Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Phase 2 Trial of Nivolumab and VEGF Inhibitors in First-Line Metastatic Renal Cell Carcinoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
MPDL3280A, an Anti-PD-L1 Monoclonal Antibody, in Metastatic Bladder Cancer
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Pharmacokinetics of MEDI4736, an Anti-PD-L1 Monoclonal Antibody, in Advanced Solid Tumors
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Immuno-Oncology: The New Frontier?
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Ipilimumab Combined with Cytotoxic Chemotherapy in Metastatic Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Doublets and Triple Combinations in Metastatic Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Stereotactic Radiosurgery and Ipilimumab for Melanoma Brain Metastases
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Peginterferon alfa-2b Combined with Ipilimumab for Advanced Melanoma
ASCO 2014 – Immuno-Oncology
,
ASCO
Conference Correspondent
Read Article
Page 2 of 3
1
2
3
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Navigating the Complex Landscape of Oral Cancer Medication
2.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
3.
New NCCN Guidelines for CLL/SLL Include Second-Generation BTK Inhibitors
Wayne Kuznar
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma